Document is current
Any future updates will be listed below
-
Authors
Abu-Qamar, Omar
Lewis, Warren
Mendonca, Luisa S. M.
De Sisternes, Luis
Chin, Adam
Alibhai, A. Yasin
Gendelman, Isaac
Reichel, Elias
Magazzeni, Stephanie
Kubach, Sophie
Durbin, Mary
Witkin, Andre J.
Baumal, Caroline R.
Duker, Jay S.
Waheed, Nadia K. https://orcid.org/0000-0002-8229-7519
-
Funding
Funding for this research was provided by:
Massachusetts Lions Eye Research Fund
Carl Zeiss Meditec AG (Device Loan)
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 2 August 2023
First Online: 11 October 2023
Declarations
:
: This study received approval by the institutional review board at the Tufts Medical Center. Informed consent was obtained from all participants.
: Not applicable.
: Warren Lewis MS is a consultant for Zeiss; Luis De Sisternes PhD is a former employee at Zeiss (employee at the time of the project); Stephanie Magazzeni PhD is an employee at Zeiss; Sophie Kubach MS is a former employee at Zeiss (employee at the time of the project); Mary Durbin PhD is a former employee (employee at the time of the project); AYA is an employee at Boston Image Reading Center; Caroline Baumal MD is a consultant for Genentech, Regeneron, Roche, Apellis, and Eyepoint. Jay S. Duker MD is an employee at EyePoint Pharmaceuticals, a consultant for Aura Biosciences, and a board member of Sesen Bio and Hubble Therapeutics; Nadia K. Waheed MD MPH is a consultant for Topcon, Complement Therapeutics, Olix Pharma, Iolyx Pharmaceuticals, Hubble, Saliogen, and Syncona, has received speaker fees from Nidek and Zeiss and equity interest from Ocudyne, Gyroscope, an employee at AGTC, has received research support to institution from Zeiss, Topcon, and Nidek (all active, all devices still at institution as part of research).The other authors have no competing interests.
